IL-21 promotes CD4 T cell responses by phosphatidylinositol 3-kinase-dependent upregulation of CD86 on B cells.

IL-21 promotes CD4 T cell responses by phosphatidylinositol 3-kinase-dependent upregulation of CD86 on B cells.
复制标题

DOI:
10.4049/jimmunol.1302082
复制
发表时间:
2014-03-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
通讯作者:
Walker LS
Walker LS
中科院分区:
其他
文献类型:
--
作者:
Attridge K;Kenefeck R;Wardzinski L;Qureshi OS;Wang CJ;Manzotti C;Okkenhaug K;Walker LS

文献摘要

参考文献

被引文献

相似文献

细胞因子IL-21是一种有效的免疫调节剂,对多种细胞类型具有不同的作用机制。IL-21在临床上用于促进肿瘤排斥反应,并且是在自身免疫情况下中和的新兴靶标。尽管具有临床潜力,但IL-21的生物学作用尚未完全了解,这种多效性细胞因子的全方位作用仍有待发现。在这项研究中,我们确定了一个新的作用IL-21作为诱导剂的共刺激配体CD 86对B淋巴细胞。CD86通过T细胞表达的CD28提供关键信号,促进T细胞响应Ag接合而活化。CD86的表达水平在体内受到严格调节,通过调节性T细胞主动降低,并响应于病原体来源的信号而增加。在这项研究中,我们证明了IL-21可以通过STAT3和PI3K依赖性机制触发有效和持续的CD86上调。我们发现,升高的CD86表达具有功能性后果的大小的CD4 T细胞反应在体外和体内。这些数据指出,CD86上调是IL-21可引起免疫调节作用的另一种机制。
The cytokine IL-21 is a potent immune modulator with diverse mechanisms of action on multiple cell types. IL-21 is in clinical use to promote tumor rejection and is an emerging target for neutralization in the setting of autoimmunity. Despite its clinical potential, the biological actions of IL-21 are not yet fully understood and the full range of effects of this pleiotropic cytokine are still being uncovered. In this study, we identify a novel role for IL-21 as an inducer of the costimulatory ligand CD86 on B lymphocytes. CD86 provides critical signals through T cell–expressed CD28 that promote T cell activation in response to Ag engagement. Expression levels of CD86 are tightly regulated in vivo, being actively decreased by regulatory T cells and increased in response to pathogen-derived signals. In this study, we demonstrate that IL-21 can trigger potent and sustained CD86 upregulation through a STAT3 and PI3K-dependent mechanism. We show that elevated CD86 expression has functional consequences for the magnitude of CD4 T cell responses both in vitro and in vivo. These data pinpoint CD86 upregulation as an additional mechanism by which IL-21 can elicit immunomodulatory effects.
DOI: 10.1038/ni.2261
发表时间: 2012-05-01
期刊: NATURE IMMUNOLOGY
影响因子: 30.5
作者:
Luethje, Katja;Kallies, Axel;Nutt, Stephen L.
通讯作者: Nutt, Stephen L.
DOI: 10.4049/jimmunol.1102885
发表时间: 2012-05-01
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Good-Jacobson KL;Song E;Anderson S;Sharpe AH;Shlomchik MJ
通讯作者: Shlomchik MJ
DOI: 10.4049/jimmunol.180.8.5393
发表时间: 2008-04-15
影响因子: 4.4
作者:
Clough, Louise E.;Wang, Chun Jing;Walker, Lucy S. K.
通讯作者: Walker, Lucy S. K.
DOI: 10.1182/blood-2007-07-099531
发表时间: 2008-05-01
期刊: BLOOD
影响因子: 20.3
作者:
Gowda, Aruna;Roda, Julie;Byrd, John C.
通讯作者: Byrd, John C.
DOI: 10.1182/blood.v94.5.1782.417a04_1782_1789
发表时间: 1999-09-01
期刊: BLOOD
影响因子: 20.3
作者:
Curiel, RE;Garcia, CS;Espinoza-Delgado, I
通讯作者: Espinoza-Delgado, I